Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease: a Novel Diagnostic Test to Predict Parkinson's Disease Risk

NCT04620980 is registered in ClinicalTrials.gov with Neuromed IRCCS as lead sponsor.

NCT NCT04620980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04620980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease: a Novel Diagnostic Test to Predict Parkinson's Disease Risk
Lead sponsor
Neuromed IRCCS
Phase
Observational
Overall status
Unknown status
Start date
June 15, 2021
Completion date
May 17, 2024
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease